Skip to main content
ALGS logo
ALGS
(NASDAQ)
Aligos Therapeutics, Inc.
$5.76-- (--)
Loading... - Market loading

Aligos Therapeutics (ALGS) Stock Price & Financial Analysis

Aligos Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.62 - $6.34
52-Week High$13.69
52-Week Low$3.98
Open$6.21
Volume63.63K
Average Volume (3M)115.26K
Market Cap64.60M
Shares Outstanding10.40M
Price to Sales (P/S)13.73
Price to Book (P/B)2.03
EV/EBITDA-0.45
Revenue (TTM)4.71M
Net Income (TTM)-90.32M
Free Cash Flow (TTM)-85.19M
EPS (TTM)$-8.70
Profit Margin-1919.68%
Operating Margin-2033.39%
Return on Equity (ROE)-284.13%
Debt to Equity0.14
50-Day MA$5.92
200-Day MA$7.13
52-Week Change-48.15%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aligos Therapeutics

What is the current stock price for ALGS?

As of the latest trading session, ALGS stock trades at $5.76. The 52-week range is $3.98–$13.69, with a day range of $5.62–$6.34.

What is the P/E ratio for ALGS?

The P/E ratio (Price-to-Earnings) for ALGS is shown in the Key Statistics section. This valuation metric helps compare Aligos Therapeutics, Inc. to industry peers.

Does ALGS pay dividends?

Aligos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALGS?

Based on 1 analyst, the consensus for ALGS is Buy.

What is the market cap of ALGS?

Aligos Therapeutics's market capitalization is $59.9M, classifying it as a micro-cap company. Aligos Therapeutics operates in the Healthcare sector within the Biotechnology industry.